Marchex Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $44M-8.6% YoYTTM through 30 Jun 2026
Net Income -$5.5MTTM through 30 Jun 2026
Free Cash Flow -$788KTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 63.4% |
| EBITDA Margin | -8.6% |
| Operating Margin | -12.5% |
| Net Margin | -12.4% |
Returns
-17.3%ROE
-13.1%ROA
Balance Sheet Health
Debt / Equity0.02x
Current Ratio2.36x
Net Debt-$9.9Mnet cash position
Cash & Equivalents$8.2M
Quality Metrics
Altman Z-Score-6.97
Piotroski F-Score3 / 9
FCF Margin-1.8%
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $45.4M
Diluted EPS-$0.13TTMFY2025: $-0.12
Dividend
$0.50Per share, FY20180.00%Yield
Capital Allocation
R&D Spend$9M
Capex Intensity0.1%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.